Cite
HARVARD Citation
Elliott, M. et al. (2018). The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism. Scientific reports. 8 (1), pp. 1-10. [Online].